Literature DB >> 15951480

Vitamin D.

Adriana S Dusso1, Alex J Brown, Eduardo Slatopolsky.   

Abstract

The vitamin D endocrine system plays an essential role in calcium homeostasis and bone metabolism, but research during the past two decades has revealed a diverse range of biological actions that include induction of cell differentiation, inhibition of cell growth, immunomodulation, and control of other hormonal systems. Vitamin D itself is a prohormone that is metabolically converted to the active metabolite, 1,25-dihydroxyvitamin D [1,25(OH)(2)D]. This vitamin D hormone activates its cellular receptor (vitamin D receptor or VDR), which alters the transcription rates of target genes responsible for the biological responses. This review focuses on several recent developments that extend our understanding of the complexities of vitamin D metabolism and actions: the final step in the activation of vitamin D, conversion of 25-hydroxyvitamin D to 1,25(OH)(2)D in renal proximal tubules, is now known to involve facilitated uptake and intracellular delivery of the precursor to 1alpha-hydroxylase. Emerging evidence using mice lacking the VDR and/or 1alpha-hydroxylase indicates both 1,25(OH)(2)D(3)-dependent and -independent actions of the VDR as well as VDR-dependent and -independent actions of 1,25(OH)(2)D(3). Thus the vitamin D system may involve more than a single receptor and ligand. The presence of 1alpha-hydroxylase in many target cells indicates autocrine/paracrine functions for 1,25(OH)(2)D(3) in the control of cell proliferation and differentiation. This local production of 1,25(OH)(2)D(3) is dependent on circulating precursor levels, providing a potential explanation for the association of vitamin D deficiency with various cancers and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951480     DOI: 10.1152/ajprenal.00336.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  385 in total

1.  The -4817 G>A (rs2238136) variant of the vitamin D receptor gene: a probable risk factor for colorectal cancer.

Authors:  Touraj Mahmoudi; Maral Arkani; Khatoon Karimi; Akram Safaei; Fatemeh Rostami; Elham Arbabi; Mohamad Amin Pourhoseingholi; Seyed Reza Mohebbi; Abdolrahim Nikzamir; Sara Romani; Shohreh Almasi; Maryam Abbaszadeh; Mohammad Vafaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia.

Authors:  Elizabeth A Hibler; Chengcheng Hu; Peter W Jurutka; Maria E Martinez; Elizabeth T Jacobs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

3.  Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats.

Authors:  Wayne A Cass; Laura E Peters; Anita M Fletcher; David M Yurek
Journal:  Neurochem Int       Date:  2011-11-22       Impact factor: 3.921

4.  Ethnic differences in 25-hydroxyvitamin D levels and response to treatment in CKD.

Authors:  Iris Sanchez; Roberto Mangoo-Karim; Jason R Stubbs; George P Yanev; James B Wetmore
Journal:  Int Urol Nephrol       Date:  2012-05-30       Impact factor: 2.370

5.  22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.

Authors:  Misaki Hirose; Tomoya Nishino; Yoko Obata; Masayuki Nakazawa; Yuka Nakazawa; Akira Furusu; Katsushige Abe; Masanobu Miyazaki; Takehiko Koji; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

6.  Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins.

Authors:  Kari E Wong; Frances L Szeto; Wenshuo Zhang; Honggang Ye; Juan Kong; Zhongyi Zhang; Xiao Jian Sun; Yan Chun Li
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-27       Impact factor: 4.310

7.  Vitamin d deficiency in patients with systemic lupus erythematosus.

Authors:  Suzan M Attar; Aisha M Siddiqui
Journal:  Oman Med J       Date:  2013-01

8.  Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.

Authors:  Joy P Walker; Jade S Hiramoto; Warren J Gasper; Philip Auyang; Michael S Conte; Joseph H Rapp; David H Lovett; Christopher D Owens
Journal:  J Vasc Surg       Date:  2014-02-28       Impact factor: 4.268

Review 9.  Klotho and aging.

Authors:  Makoto Kuro-o
Journal:  Biochim Biophys Acta       Date:  2009-02-20

Review 10.  Vitamin D and Calcimimetics in Cardiovascular Disease.

Authors:  Kenneth Lim; Takayuki Hamano; Ravi Thadhani
Journal:  Semin Nephrol       Date:  2018-05       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.